Report Categories
View AllRecent Articles
View All
Spce Stock Analysis Virgin Galactic Holdings Inc. At 2.4 Post 1.23 Daily Dip 20260401
Will Oculis Ocs Stock Go Higher Price At 27.00 Up 2.27 20260408
Is Hinge Health Hnge Stock Cheap At Current Price Price At 38.02 Down 2.99 20260407
Is Alarum Alar Stock Near Support Price At 6.30 Up 2.85 20260408
What CSG CSGS segment performance reveals Q1 2026 Profit Exceeds Views
The working capital efficiency at Pimco PML PML Q4 Earnings Pimco Municipal Fund Reports Income and Distributions
Why Morgan MSD might be the steady performer you need 054 20260507
How Vine Hill VCIC competitive position shows up in earnings VCIC Quarterly Earnings Vine Hill Capital Investment Corp Posts Report
SP Global SPGI Announces 2026 VirtualOnly Annual Shareholder Meeting Scheduled for May 20
How Investcorp ICMB margins compare to industry leaders Softens 20260508
What gross margin for Trinity TRIB Q4 2024 Earnings Fall Short
What OneIM OIMAU management said that matters most
Kalaris Therapeutics KLRS Delivers Q1 2026 Beat EPS 046 vs 053 Expected
Kodiak Gas KGS Q1 2026 Earnings Why the Beat Matters
Texas TXN Stock Analysis Falls 070 Watching 28557 20260518
Iveda IVDAW Steady at 004 Awaiting Next Catalyst 20260515
Inherited Home Sale Strategy Navigating Capital Gains After Property Inheritance
Evercore ISI Lowers Price Target on Illinois Tool Works ITW Amid Revised Outlook
Japan Inc Maintains Cautious Stance on Philippine Business as President Marcos Visits Tokyo
Stellantis Turnaround Plan and Oura IPO Filing Highlight Morning Market Movers
Delivery Hero Shares Surge on Potential Uber Takeover Offer
Vestas Wind Systems Shares Decline as Company Warns Margins at Low End of Guidance
PRTA Q1 2026 Earnings Biotech Surprises with Positive EPS on Milestone Gain Stock Rises
CLBT Q1 2026 Earnings Strong EPS Beat Highlights Profitability Improvement
OCSL Q1 2026 Earnings Slight EPS Beat Amid Stable Portfolio Performance
SLM Q1 2026 Earnings EPS Surges Past Estimates Stock Gains
NanoX Imaging Ltd NNOX Q4 2025 Earnings Significant EPS Miss Amid Ongoing Commercialization Efforts
KALV Q1 2026 Earnings Narrower Loss Beats Expectations Clinical Pipeline Progress Underway